PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Completed

Phase 4 Results

References

Publications

  • Kase CS, Albers GW, Bladin C, Fieschi C, Gabbai AA, O'Riordan W, Pineo GF; on behalf of the PREVAIL Investigators. Neurological Outcomes in Patients With Ischemic Stroke Receiving Enoxaparin or Heparin for Venous Thromboembolism Prophylaxis. Subanalysis of the Prevention of VTE After Acute Ischemic Stroke With LMWH (PREVAIL) Study. Stroke. 2009 Aug 20; [Epub ahead of print] Pubmed ID:19696423
  • Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF; PREVAIL Investigators. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet. 2007 Apr 21;369(9570):1347-55. Pubmed ID:17448820

Related Links

Sources for Trial Information